A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Conditions: Alopecia Areata Interventions: Drug: Rezpegaldesleukin; Drug: Placebo Sponsors: Nektar Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials